Thought Leadership | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Standard Essential Patents

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Search results

Blog | October 11, 2023

ITC Monthly Wrap-Up: September 2023

News | October 10, 2023

Fish & Richardson Recognized with Mansfield 6.0 Certification Plus from Diversity Lab

Event | October 10, 2023

2023 Kisaco Life Sciences Strategy Summit on IP & Exclusivity

News | October 09, 2023

Fish & Richardson Principal Jennifer Huang Named a 2023 Notable Woman in Law by Twin Cities Business

Event | October 05, 2023

PTAB Bar Association 2023 Thought Leader Summit

News | October 05, 2023

Fish & Richardson Ranked Highly by Managing IP; Attorneys Named IP Stars

News | October 02, 2023

Fish & Richardson Attorneys Named to IAM's 2023 Strategy 300 List

Blog | October 02, 2023

What’s New in Director Review?

Event | September 29, 2023

Delaware State Bar Association 100th Anniversary Celebration

Event | September 28, 2023

2023 Midwest Intellectual Property Institute

Event | September 27, 2023

World Trademark Review: Brand Strategy Summit USA

Blog | September 25, 2023

Federal Circuit Evaluates Enablement for Antibody Claims for the First Time Since Amgen v. Sanofi in Baxalta Inc. et al. v. Genentech, Inc.